Close Menu

NEW YORK – PierianDx will integrate the Pillar Biosciences PiVAT cancer bioinformatics pipeline into its core technology platform, the companies announced Wednesday. Under the new partnership, Pillar Bio, which has co-headquarters in Boston and Shanghai, will market PieranDx clinical genomic reports along with its own cancer profiling assays.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.